Purchase any WEBINAR and get
10% Off
CODE: SAVE10
T&C applicable, please referFAQ
Validity : 31st Mar'26 to 10th Apr'26
New EU Medical Device Regulations - What’s the Impact
Key Take Away:
Pharma Times Magazine has called the new EU medical device regulation “A new landscape for medical devices.” The new regulation has provided manufacturers and regulators alike with a much broader definition of both medical devices and in vitro diagnostic medical devices. This much broader definition will contribute to a significant improvement of medical device products in terms of patient and user safety, device reliability, and overall quality.
At the completion of this webinar participant’s will be able to:
- Explain how the new Medical Device Regulation is structured
- Define/explain the key sections of the regulation
- Explain the transition process from the Medical Device directives to the current Medical Device Regulation
- Define the key differences between the MDD and the new MDR to include – notified bodies, clinical evidence, pre-market, transparency and traceability, governance and oversight
- The and descript the changes to regulations from the Medical Device Directives
- Define the process and options for conducting the conformity assessment
- Explain the expanded role of the notified body
- Explain how this new regulation will impact US companies
Overview of the webinar
Partially as a result of the Poly Implant Prothèse breast implant scandal, where a French manufacturer substituted approved medical-grade silicone with industrial-grade silicone that ruptured causing a variety of serious medical implants up to and including death, the European Commission began developing changes to their Medical Device Directives to prevent this type of an issue from happening again. The changes resulted in the drafting of a totally new Medical Device Regulation is now the law in the EU.
The new EMDR is the most extensive medical device regulation Europe has seen since the 1990’s.
Understanding the contents of this regulation and its implications is crucial to the effective design, development, marketing, and utilization of medical devices in the EU.
Who should attend?
Anyone involved in the design, development, marketing, and management of medical devices in the European Union. The specific positions and functions are varied and not restricted to any one function or job title.
- Audit and Compliance Personnel / Risk Managers
- Research and Development Engineers
- Vice-Presidents, Directors, and Managers of Medical Device Design Functions
- Medical Device Marketing Personnel
Why should you attend?
The current Medical Device Regulation stands at 350+ pages and is a complex array of regulations written in the normal legalese. There are many changes that anyone designing, manufacturing, and/or marketing medical devices into the EU needs to be aware of when compared to the original Medical Device Directives. This webinar will detail the changes and discuss their implications, and provide a greater understanding of the regulation medical device manufacturers.
Faculty - Mr.Charles H. Paul
Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm. Charles is a management consultant, instructional designer and regulatory consultant and has led C. H. Paul Consulting, Inc. since its inception over 25 years ago. He regularly consults with Fortune 500 pharmaceutical, medical device, and biotechnology firms assisting them in achieving human resource, regulatory, and operational excellence. He is a regular presenter of webinars and on-site seminars in a variety of related subjects from documentation development to establishing compliant preventive maintenance systems.